REVXF (Revenio Group Oyj) Accounts Payable: $18.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

REVXF Revenio Group Oyj REVXF
82 GF Score
Price $16.41
GF Value $40.80
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj Accounts Payable?

Revenio Group Oyj REVXF 82 Accounts Payable is $18.3 Mil as of Mar. 2026. GuruFocus rates REVXF with a GF Score™ of 82/100 and a GF Value™ of $40.80 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Revenio Group Oyj's Accounts Payable for the quarter that ended in Mar. 2026 was $18.3 Mil.

Revenio Group Oyj's quarterly Accounts Payable declined from Sep. 2025 ($13.5 Mil) to Dec. 2025 ($9.8 Mil) but then increased from Dec. 2025 ($9.8 Mil) to Mar. 2026 ($18.3 Mil).

Revenio Group Oyj's annual Accounts Payable declined from Dec. 2023 ($7.4 Mil) to Dec. 2024 ($7.3 Mil) but then increased from Dec. 2024 ($7.3 Mil) to Dec. 2025 ($9.8 Mil).

Revenio Group Oyj Accounts Payable Related Terms

Revenio Group Oyj Accounts Payable Historical Data

* Premium members only.

The historical data trend for Revenio Group Oyj's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revenio Group Oyj Accounts Payable Chart

Revenio Group Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.69 8.37 7.41 7.33 9.83

Revenio Group Oyj Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.78 14.76 13.50 9.83 18.27
REVXF
82GF Score
Revenio Group Oyj REVXF
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revenio Group Oyj Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $18.3 Mil mean?
Revenio Group Oyj (REVXF) has a Accounts Payable of $18.3 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Revenio Group Oyj and its competitors.
Is Revenio Group Oyj's Accounts Payable too high?
Revenio Group Oyj's current Accounts Payable is $18.3 Mil. Overall, Revenio Group Oyj has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Accounts Payable compare to ABT and SYK?
Revenio Group Oyj's Accounts Payable of $18.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Revenio Group Oyj and its competitors. Revenio Group Oyj's current Accounts Payable is $18.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Based on GuruFocus' analysis, Revenio Group Oyj (REVXF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.80, compared to a current price of $16.41 — trading 59.8% below its estimated fair value. The current Accounts Payable is $18.3 Mil. Revenio Group Oyj's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Revenio Group Oyj (REVXF), the current Accounts Payable is $18.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revenio Group Oyj (REVXF) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of $16.41 is trading 59.8% below its estimated GF Value™ of $40.80. GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.

Key valuation signals for REVXF:

  • Accounts Payable: $18.3 Mil
  • GF Value™: $40.80 vs. price of $16.41 (59.8% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the REVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
82GF Score

Get the complete analysis for REVXF

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.41
Price
$40.80
GF Value